Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2720-2726
Published online before print May 23, 2005, doi: 10.1161/CIRCULATIONAHA.104.472498
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/21/2720    most recent
CIRCULATIONAHA.104.472498v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, L.
Right arrow Articles by Vincent, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, L.
Right arrow Articles by Vincent, G. M.
Related Collections
Right arrow Clinical genetics
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2005;111:2720-2726.)
© 2005 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Electrocardiographic Features in Andersen-Tawil Syndrome Patients With KCNJ2 Mutations

Characteristic T-U–Wave Patterns Predict the KCNJ2 Genotype

Li Zhang, MD; D. Woodrow Benson, MD, PhD; Martin Tristani-Firouzi, MD; Louis J. Ptacek, MD; Rabi Tawil, MD; Peter J. Schwartz, MD; Alfred L. George, MD; Minoru Horie, MD, PhD; Gregor Andelfinger, MD; Gregory L. Snow, PhD; Ying-Hui Fu, PhD; Michael J. Ackerman, MD, PhD; G. Michael Vincent, MD

From the LDS Hospital, Salt Lake City, Utah (L.Z., G.S., G.M.V.); Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio (D.W.B., G.A.); University of Utah, Salt Lake City (L.Z., M.T.F., G.M.V.); Howard Hughes Medical Institute, University of California, San Francisco (L.J.P., Y.H.F.); University of Rochester School of Medicine and Dentistry, Rochester, NY (R.T.); University of Pavia and Policlinico S. Matteo, IRCCS, Pavia, Italy (P.J.S.); Vanderbilt University School of Medicine, Nashville, Tenn (A.L.G.); Shiga University of Medical Science, Seta-Tsukinowa, Japan (M.H.); and Mayo Clinic College of Medicine (M.J.A.), Rochester, Minn.

Correspondence to G. Michael Vincent, MD, Department of Medicine, LDS Hospital, 324 10th Ave, Suite 130, Salt Lake City, Utah 84103. E-mail ldgvince{at}ihc.com

Received May 4, 2004; revision received January 11, 2005; accepted January 20, 2005.

Background— The ECG features of Andersen-Tawil syndrome (ATS) patients with KCNJ2 mutations (ATS1) have not been systematically assessed. This study aimed to define ECG features of KCNJ2 mutation carriers, to determine whether characteristic T-U–wave patterns exist, and to establish whether T-U patterns predict the ATS1 genotype.

Methods and Results— In phase I, evaluation of T-U morphology in ECGs of 39 KCNJ2 mutation carriers identified characteristic T-U patterns: prolonged terminal T downslope, wide T-U junction, and biphasic and enlarged U waves. In phase II, ATS1 genotype prediction by T-U pattern was evaluated in the next 147 ECGs (57 other KCNJ2 mutation carriers, 61 unaffected family members, and 29 ATS patients without KCNJ2 mutations), with a sensitivity of 84% and specificity of 97%. Characteristic T-U patterns were present in 91% (87/96), in whom an enlarged U wave was predominant (73%). In phase III, QTc, QUc, and T- and U-wave duration/amplitude were compared in the 96 ATS1, 29 non-KCNJ2 ATS, and 75 normal subjects. In ATS1 patients, QUc, U-wave duration and amplitude, and QTc were all increased (P<0.001), but median QTc and interquartile range (IQR) were just 440 ms (IQR, 28 ms) compared with 420 ms (IQR, 20 ms) in normal subjects and 425 ms (IQR, 48 ms) in ATS non-KCNJ2 patients.

Conclusions— In ATS1 patients, gene-specific T-U–wave patterns resulting from decreased IK1 owing to KCNJ2 mutations can aid diagnosis and direct genotyping. The normal QTc, distinct ECG, and other clinical features distinguish ATS1 from long-QT syndrome, and it is best designated as ATS1 rather than LQT7.


Key Words: arrhythmia • electrocardiography • genetics




This article has been cited by other articles:


Home page
Circ Arrhythm ElectrophysiolHome page
G. M. Vincent
Genotyping Has a Minor Role in Selecting Therapy for Congenital Long-QT Syndromes at Present
Circ Arrhythm Electrophysiol, August 1, 2008; 1(3): 227 - 233.
[Full Text] [PDF]


Home page
EuropaceHome page
D. J. Fox, G. J. Klein, A. Hahn, A. C. Skanes, L. J. Gula, R. K. Yee, R. N. Subbiah, and A. D. Krahn
Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome
Europace, August 1, 2008; 10(8): 1006 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Morita, D. P. Zipes, S. T. Morita, and J. Wu
Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen-Tawil syndrome
Cardiovasc Res, August 1, 2007; 75(3): 510 - 518.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Poelzing and R. Veeraraghavan
Heterogeneous ventricular chamber response to hypokalemia and inward rectifier potassium channel blockade underlies bifurcated T wave in guinea pig
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3043 - H3051.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Sung, S.-N. Wu, J.-S. Wu, H.-D. Chang, and C.-H. Luo
Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study
Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2597 - H2605.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
BrainHome page
S. L. Venance, S. C. Cannon, D. Fialho, B. Fontaine, M. G. Hanna, L. J. Ptacek, M. Tristani-Firouzi, R. Tawil, R. C. Griggs, and the CINCH investigators
The primary periodic paralyses: diagnosis, pathogenesis and treatment
Brain, January 1, 2006; 129(1): 8 - 17.
[Abstract] [Full Text] [PDF]